Company Filing History:
2 out of 164 
2 out of 38 
1 out of 2,285 
Years Active: 2012-2019
Title: Swati Gupta: Innovator in Biotech Patents
Introduction
Swati Gupta is a prominent inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of assays for detecting neurotoxins and measuring receptor activity. With a total of three patents to her name, Gupta's work has the potential to impact various medical applications.
Latest Patents
Gupta's latest patents include a highly sensitive cell-based assay designed to detect the presence of active botulinum neurotoxin serotype A. This innovative method allows for the detection of extremely low amounts of the neurotoxin in complex samples such as blood, plasma, and serum. Another notable patent is her GLP-1 receptor agonist bioassay, which provides cell-based bioassays for measuring the activity of GLP-1 receptor agonist compounds. These bioassays are crucial for quantitatively determining cAMP generated in samples containing these compounds, thereby correlating the amount of cAMP to the agonist activity.
Career Highlights
Throughout her career, Swati Gupta has worked with leading pharmaceutical companies, including Amylin Pharmaceuticals, Inc. and AstraZeneca Pharmaceuticals LP. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research in the biotech sector.
Collaborations
Gupta has collaborated with notable professionals in her field, including Michalis